Dong Sung Bio Pharm.Co.,Ltd. (KRX: 002210)
South Korea
· Delayed Price · Currency is KRW 4,475.00
+55.00 (1.24%)
Nov 18, 2024, 3:30 PM KST
Dong Sung Bio Pharm.Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2006 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '11 Dec 31, 2011 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2006 - 2005 |
| Operating Revenue | 78,442 | 78,442 | 71,926 | 68,724 | 62,231 | 60,319 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | - | Upgrade
|
| Revenue | 78,442 | 78,442 | 71,926 | 68,724 | 62,231 | 60,319 | Upgrade
|
| Revenue Growth (YoY) | 13.99% | 9.06% | 4.66% | 10.43% | 3.17% | -4.15% | Upgrade
|
| Cost of Revenue | 33,231 | 33,231 | 32,043 | 27,721 | 25,509 | 23,927 | Upgrade
|
| Gross Profit | 45,211 | 45,211 | 39,884 | 41,003 | 36,722 | 36,393 | Upgrade
|
| Selling, General & Admin | 37,891 | 37,891 | 38,841 | 38,066 | 33,821 | 31,794 | Upgrade
|
| Research & Development | 377.33 | 377.33 | 193.1 | 332.14 | 252.34 | 169.71 | Upgrade
|
| Other Operating Expenses | 239.02 | 239.02 | 244.52 | 369.39 | 267.24 | 600.87 | Upgrade
|
| Operating Expenses | 42,107 | 42,107 | 42,992 | 39,898 | 35,237 | 34,837 | Upgrade
|
| Operating Income | 3,104 | 3,104 | -3,109 | 1,105 | 1,486 | 1,556 | Upgrade
|
| Interest Expense | -2,003 | -2,003 | -2,297 | -1,701 | -1,828 | -1,965 | Upgrade
|
| Interest & Investment Income | 98.47 | 98.47 | 370.71 | 260.91 | 548.17 | 349.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -117.82 | -117.82 | -248.53 | -162.58 | 996.91 | 68.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 679.71 | 679.71 | 226.85 | 1,067 | 457.9 | 302.56 | Upgrade
|
| EBT Excluding Unusual Items | 1,762 | 1,762 | -5,057 | 568.35 | 1,660 | 310.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.26 | -6.26 | 102.22 | 104.42 | -805.14 | -649.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | -7.31 | -7.31 | 7.81 | 3.23 | 4,557 | 3,811 | Upgrade
|
| Asset Writedown | - | - | - | - | -175.52 | - | Upgrade
|
| Pretax Income | 1,749 | 1,749 | -4,947 | 675.99 | 5,236 | 3,472 | Upgrade
|
| Income Tax Expense | 47.5 | 47.5 | 2,908 | 107.56 | 1,580 | 815.59 | Upgrade
|
| Net Income | 1,701 | 1,701 | -7,855 | 568.43 | 3,657 | 2,656 | Upgrade
|
| Net Income to Common | 1,701 | 1,701 | -7,855 | 568.43 | 3,657 | 2,656 | Upgrade
|
| Net Income Growth | - | - | - | -84.45% | 37.68% | -10.06% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 17 | Upgrade
|
| Shares Change (YoY) | -2.59% | -1.98% | -0.79% | - | 4.39% | -11.41% | Upgrade
|
| EPS (Basic) | 96.34 | 96.34 | -436.00 | 31.30 | 201.38 | 152.69 | Upgrade
|
| EPS (Diluted) | 96.34 | 96.34 | -436.00 | 31.30 | 201.38 | 152.69 | Upgrade
|
| EPS Growth | - | - | - | -84.45% | 31.89% | 1.52% | Upgrade
|
| Free Cash Flow | -3,024 | -3,024 | 2,837 | -5,743 | -782.29 | 1,202 | Upgrade
|
| Free Cash Flow Per Share | -171.26 | -171.26 | 157.50 | -316.25 | -43.08 | 69.11 | Upgrade
|
| Dividend Per Share | 30.000 | 30.000 | - | 30.000 | 30.000 | 30.000 | Upgrade
|
| Dividend Growth | 0% | - | - | 0% | 0% | -25.00% | Upgrade
|
| Gross Margin | 57.64% | 57.64% | 55.45% | 59.66% | 59.01% | 60.33% | Upgrade
|
| Operating Margin | 3.96% | 3.96% | -4.32% | 1.61% | 2.39% | 2.58% | Upgrade
|
| Profit Margin | 2.17% | 2.17% | -10.92% | 0.83% | 5.88% | 4.40% | Upgrade
|
| Free Cash Flow Margin | -3.86% | -3.86% | 3.95% | -8.36% | -1.26% | 1.99% | Upgrade
|
| EBITDA | 4,612 | 4,612 | -1,599 | 2,421 | 2,872 | 3,021 | Upgrade
|
| EBITDA Margin | 5.88% | 5.88% | -2.22% | 3.52% | 4.61% | 5.01% | Upgrade
|
| D&A For EBITDA | 1,507 | 1,507 | 1,510 | 1,316 | 1,386 | 1,465 | Upgrade
|
| EBIT | 3,104 | 3,104 | -3,109 | 1,105 | 1,486 | 1,556 | Upgrade
|
| EBIT Margin | 3.96% | 3.96% | -4.32% | 1.61% | 2.39% | 2.58% | Upgrade
|
| Effective Tax Rate | 2.72% | 2.72% | - | 15.91% | 30.17% | 23.49% | Upgrade
|
| Revenue as Reported | - | - | - | 68,724 | 62,231 | 60,319 | Upgrade
|
| Advertising Expenses | 8,990 | 8,990 | 11,058 | 10,653 | 11,240 | 10,534 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.